UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis
NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD
Taking everything into account, UFPT scores 6 out of 10 in our fundamental rating. UFPT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. UFPT scores excellent on profitability, but there are some minor concerns on its financial health. UFPT is growing strongly while it is still valued neutral. This is a good combination! These ratings would make UFPT suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year UFPT was profitable.
UFPT had a positive operating cash flow in the past year.
In the past 5 years UFPT has always been profitable.
UFPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 9.88%, UFPT belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
With an excellent Return On Equity value of 17.60%, UFPT belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
UFPT has a better Return On Invested Capital (13.23%) than 95.24% of its industry peers.
UFPT had an Average Return On Invested Capital over the past 3 years of 11.64%. This is above the industry average of 7.87%.
The 3 year average ROIC (11.64%) for UFPT is below the current ROIC(13.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROIC | 13.23% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
1.3 Margins
UFPT has a Profit Margin of 11.59%. This is amongst the best in the industry. UFPT outperforms 88.36% of its industry peers.
UFPT's Profit Margin has improved in the last couple of years.
UFPT's Operating Margin of 16.57% is amongst the best of the industry. UFPT outperforms 87.83% of its industry peers.
In the last couple of years the Operating Margin of UFPT has grown nicely.
UFPT's Gross Margin of 28.99% is on the low side compared to the rest of the industry. UFPT is outperformed by 76.19% of its industry peers.
In the last couple of years the Gross Margin of UFPT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% |
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
UFPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, UFPT has more shares outstanding
The debt/assets ratio for UFPT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.17 indicates that UFPT is not in any danger for bankruptcy at the moment.
UFPT's Altman-Z score of 6.17 is amongst the best of the industry. UFPT outperforms 84.13% of its industry peers.
UFPT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as UFPT would need 3.10 years to pay back of all of its debts.
UFPT has a Debt to FCF ratio of 3.10. This is amongst the best in the industry. UFPT outperforms 87.83% of its industry peers.
UFPT has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
UFPT has a Debt to Equity ratio (0.47) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Altman-Z | 6.17 |
ROIC/WACC1.48
WACC8.93%
2.3 Liquidity
UFPT has a Current Ratio of 2.58. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
UFPT has a Current ratio of 2.58. This is comparable to the rest of the industry: UFPT outperforms 49.21% of its industry peers.
UFPT has a Quick Ratio of 1.45. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT's Quick ratio of 1.45 is on the low side compared to the rest of the industry. UFPT is outperformed by 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.35% over the past year.
UFPT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.55% yearly.
The Revenue has grown by 34.43% in the past year. This is a very strong growth!
UFPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.52% yearly.
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
3.2 Future
UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.28% yearly.
UFPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.93% yearly.
EPS Next Y14.03%
EPS Next 2Y13.82%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year19.86%
Revenue Next 2Y12.56%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.05, UFPT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 75.13% of the companies in the same industry.
When comparing the Price/Earnings ratio of UFPT to the average of the S&P500 Index (26.03), we can say UFPT is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 23.28, the valuation of UFPT can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 75.13% of the companies listed in the same industry.
UFPT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.05 | ||
| Fwd PE | 23.28 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 75.66% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, UFPT is valued cheaper than 80.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.83 | ||
| EV/EBITDA | 18.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)2
PEG (5Y)1.19
EPS Next 2Y13.82%
EPS Next 3Y14.28%
5. Dividend
5.1 Amount
No dividends for UFPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
229.2
-10.1 (-4.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners102.26%
Inst Owner Change7.21%
Ins Owners5.91%
Ins Owner Change3.61%
Market Cap1.76B
Analysts78
Price Target388.62 (69.55%)
Short Float %14.02%
Short Ratio8.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.07%
Min EPS beat(2)3.81%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)9.7%
Min EPS beat(4)3.81%
Max EPS beat(4)14.29%
EPS beat(8)7
Avg EPS beat(8)15.09%
EPS beat(12)11
Avg EPS beat(12)31.68%
EPS beat(16)14
Avg EPS beat(16)26.54%
Revenue beat(2)1
Avg Revenue beat(2)1.69%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)3.67%
Revenue beat(4)3
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)7.43%
Revenue beat(8)6
Avg Revenue beat(8)2.62%
Revenue beat(12)10
Avg Revenue beat(12)5.5%
Revenue beat(16)14
Avg Revenue beat(16)5.64%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.58%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.31%
EPS NY rev (3m)-0.47%
Revenue NQ rev (1m)3.72%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.31%
Revenue NY rev (3m)1.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.05 | ||
| Fwd PE | 23.28 | ||
| P/S | 3.21 | ||
| P/FCF | 29.83 | ||
| P/OCF | 25.24 | ||
| P/B | 4.88 | ||
| P/tB | 64.13 | ||
| EV/EBITDA | 18.74 |
EPS(TTM)8.17
EY3.56%
EPS(NY)9.85
Fwd EY4.3%
FCF(TTM)7.68
FCFY3.35%
OCF(TTM)9.08
OCFY3.96%
SpS71.3
BVpS46.96
TBVpS3.57
PEG (NY)2
PEG (5Y)1.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROCE | 16.13% | ||
| ROIC | 13.23% | ||
| ROICexc | 13.57% | ||
| ROICexgc | 34.55% | ||
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% | ||
| FCFM | 10.78% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Debt/EBITDA | 1.59 | ||
| Cap/Depr | 65.69% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 9.01 | ||
| Cash Conversion | 65.12% | ||
| Profit Quality | 92.97% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 6.17 |
F-Score4
WACC8.93%
ROIC/WACC1.48
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
EPS Next Y14.03%
EPS Next 2Y13.82%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
Revenue Next Year19.86%
Revenue Next 2Y12.56%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
EBIT growth 1Y49.25%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year46.15%
EBIT Next 3Y21.52%
EBIT Next 5YN/A
FCF growth 1Y552.02%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y207.54%
OCF growth 3Y67.03%
OCF growth 5Y16.35%